$0.01
+92.19%Price chart
Sep 4Sep 15Sep 18Sep 28Oct 5Oct 8Oct 13Oct 19
Key dataOct 19, 2026
Open$0.01
From 52W high−76.79%
Volume57458.00
Market cap$21622.17
P/E (TTM)—
P/S (TTM)1.5x
Div yield—
Key dataOct 19, 2026
Open
$0.01
From 52W high
−76.79%
Volume
57458.00
Market cap
$21622.17
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.9x
P/E (TTM)
—
RSI (14)
37.7
MomentumView details →
1D Return
+92.19%
YTD Return
−75.29%
SummaryUpdated Jun 1, 2026
Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) is a biotechnology company founded in 2017 and headquartered in Chicago, Illinois. The company went public in January 2022 and specializes in developing and commercializing advanced diagnostic tests for cardiovascular disease using epigenetic technology. As a relatively young public company in the precision medicine space, Cardio Diagnostics focuses on creating innovative testing solutions that can help predict and assess cardiovascular risk before symptoms appear.
Similar companies
Latest newsMore news →